Apollo

The company produces a wearable therapeutic device that is clinically proven to address problems of the nervous system. In fact, Apollo Neuro is the first scientifically validated wearable that improves the body’s resilience to stress to enhance sleep, relaxation, and other states of mind. The University of Pittsburgh developed the underlying technology.

Its initial market is stress and sleep management, a multibillion-dollar sector. Afterwards, the company can expand both horizontally and/or vertically. For instance, Apollo may choose to license its technology to be incorporated into other wearables and it can also enter new health verticals such as maternity care. Lastly, the science driving the product is promising. The team conducted clinical research for five years to develop the device. The wearable has demonstrated efficacy in six clinical trials with 13 more underway.